209 related articles for article (PubMed ID: 15247189)
1. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.
Reynaert H; Rombouts K; Vandermonde A; Urbain D; Kumar U; Bioulac-Sage P; Pinzani M; Rosenbaum J; Geerts A
Gut; 2004 Aug; 53(8):1180-9. PubMed ID: 15247189
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1.
Reynaert H; Vaeyens F; Qin H; Hellemans K; Chatterjee N; Winand D; Quartier E; Schuit F; Urbain D; Kumar U; Patel YC; Geerts A
Gastroenterology; 2001 Oct; 121(4):915-30. PubMed ID: 11606505
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.
Bläker M; Schmitz M; Gocht A; Burghardt S; Schulz M; Bröring DC; Pace A; Greten H; De Weerth A
J Hepatol; 2004 Jul; 41(1):112-8. PubMed ID: 15246216
[TBL] [Abstract][Full Text] [Related]
5. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Liu HL; Huo L; Wang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
[TBL] [Abstract][Full Text] [Related]
7. Expression of stem cell factor receptor c-kit in human nontumoral and tumoral hepatic cells.
Mansuroglu T; Baumhoer D; Dudas J; Haller F; Cameron S; Lorf T; Füzesi L; Ramadori G
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1206-11. PubMed ID: 19491699
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
[TBL] [Abstract][Full Text] [Related]
9. Expression of subtypes of somatostatin receptors in hepatic stellate cells.
Song SH; Leng XS; Li T; Qin ZZ; Peng JR; Zhao L; Wei YH; Yu X
World J Gastroenterol; 2004 Jun; 10(11):1663-5. PubMed ID: 15162546
[TBL] [Abstract][Full Text] [Related]
10. Relationship between somatostatin receptors and activation of hepatic stellate cells.
Pan Q; Li DG; Lu HM; Lu LY; You HN; Xu QF
Chin Med J (Engl); 2004 Nov; 117(11):1665-9. PubMed ID: 15569483
[TBL] [Abstract][Full Text] [Related]
11. [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2].
Xie Y; Tang CW; Wang CH
Ai Zheng; 2005 Aug; 24(8):965-9. PubMed ID: 16086874
[TBL] [Abstract][Full Text] [Related]
12. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
[TBL] [Abstract][Full Text] [Related]
13. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
14. [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma].
Xie YM; Li X; Yan LN; Wei B; Wang CH; Tang CW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):710-6. PubMed ID: 26619541
[TBL] [Abstract][Full Text] [Related]
15. MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis.
Grudé P; Conti F; Mennecier D; Louvel A; Houssin D; Weill B; Calmus Y
Cancer Lett; 2002 Dec; 186(1):107-13. PubMed ID: 12183082
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations.
Abdel-Rahman O; Lamarca A; Valle JW; Hubner RA
Endocr Relat Cancer; 2014; 21(6):R485-93. PubMed ID: 25336571
[TBL] [Abstract][Full Text] [Related]
18. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
[TBL] [Abstract][Full Text] [Related]
19. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
[TBL] [Abstract][Full Text] [Related]
20. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells.
Castagnetta LA; Agostara B; Montalto G; Polito L; Campisi I; Saetta A; Itoh T; Yu B; Chen S; Carruba G
Cancer Res; 2003 Aug; 63(16):5041-5. PubMed ID: 12941832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
